Citations 1
Phase 1b/2 trial of cancer stemness inhibitor napabucasin (NAPA) + nab-paclitaxel (nPTX) and gemcitabine (Gem) in metastatic pancreatic adenocarcinoma (mPDAC).
Starodub, Alexander, El‐Rayes, Bassel F. , Shahda, Safi, O’Neil, Bert H. , Shaib, Walid L. , Hanna, Wahid T., Mikhail, Sameh , Neki, A., Chang, Yue , Dai, Xiaoshu, Li, Wei , Brooks, Emily , Oh, Cindy , Borodyansky, Laura, Li, Chiang, El-Rayes, Bassel F , Bekaii‐Saab, Tanios , Noonan, Anne M. , Brooks, Emily
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 4110-4110
